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Abstract
The relationship of exhaled ethane and n-pentane to exhaled NO, carbonylated proteins, and
indoor/outdoor atmospheric pollutants were examined in order to evaluate ethane and n-pentane as
potential markers of airway inflammation and/or oxidative stress. Exhaled NO and carbonylated
proteins were found to have no significant associations with either ethane (p = 0.96 and p = 0.81,
respectively) or n-pentane (p = 0.44 and 0.28, respectively) when outliers were included. In the
case where outliers were removed n-pentane was found to be inversely associated with
carbonylated proteins. Exhaled hydrocarbons adjusted for indoor hydrocarbon concentrations were
instead found to be positively associated with air pollutants (NO, NO2 and CO), suggesting
pollutant exposure is driving exhaled hydrocarbon concentrations. Given these find-ings, ethane
and n-pentane do not appear to be markers of airway inflammation or oxidative stress.
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Introduction
Oxidative stress is a physiological condition that occurs when there is an imbalance of
oxidants and antioxidants, favouring the former, and can arise from oxidants produced
within the body as well as exposure to atmospheric oxidants. Under normal conditions
reactive oxygen species (ROS) are removed by a number of different antioxidant enzymes,
including superoxide dismutase, catalase, or glutathione peroxidase (Sies 1985). When an
imbalance of oxidants and antioxidants occurs these removal processes are no longer
effective and oxidative damage can be inflicted on macromolecules such as lipids, proteins,
carbohydrates, and nucleic acids.
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The presence of the hydrocarbons ethane and n-pentane in exhaled breath as a result of lipid
peroxidation is of particular interest to this study. Lipid peroxidation occurs by unspecific
oxidation of polyunsaturated fatty acids (PUFA), via abstraction of a hydrogen from a
methylene carbon on the fatty acid chain, and results in toxic lipid peroxides and
hydroperoxides (Halliwell & Chirico 1993). In the presence of iron-containing compounds
(e.g. haemoglobin, cysteine–FeCl3 complex or EDTA–Fe3+) lipid hydroperoxides
decompose via complex decomposition reactions yielding a variety of fragmentation
products including short chain alkanes such as ethane and n-pentane (Horvat et al. 1964,
Sevanian & Hochstein 1985). It is widely thought that oxidation of ω-6-polyunsaturated
fatty acids and ω-3-polyunsaturated fatty acids result in n-pentane and ethane cleavage
products, respectively (Sies 1986). Consequently, numerous studies have examined short
chain alkanes in exhaled breath in attempts to demonstrate their potential use as biomarkers
of oxidative stress (Dillard et al. 1978, Drury et al. 1997, Pryor & Godber 1991, Paredi et al.
2000, Phillips et al. 2000, Aghdassi & Allard 2000, Cope 2005, Kanoh et al. 2005, Cope et
al. 2006, Solga et al. 2006, Lärstad et al. 2007). While clinical studies have found between-
subject differences in exhaled hydrocarbons, a methods development study by Drury et al.
(1997), is one of the few studies that examined within-subject changes.
Previous studies have primarily focused on oxidative stress caused by disease or clinical
conditions (Drury et al. 1997, Paredi et al. 2000, Aghdassi & Allard 2000, Cope 2005,
Kanoh et al. 2005, Cope et al. 2006, Solga et al. 2006). Exhaled hydrocarbons may be useful
for distinguishing between diseased individuals, but their sensitivity as biomarkers of acute
pro-oxidant effects is not well understood. Exposure to a highly oxidizing environment
containing primary and secondary pollutants from anthropogenic sources can also be a
source of oxidative stress to the human body. Ozone (O3) and nitrogen oxides (NO and
NO2) are common air pollutants and are considered to be important atmospheric gases that
initiate lipid peroxidation (Cross et al. 2001, Montuschi et al. 2002).
Highly polluted oxidizing environments can cause inflammation of the respiratory track,
which has previously been correlated with oxidative stress (Sies 1986). However, there are
few data evaluating the relationship of biomarkers of airway inflammation to oxidative
stress in humans (Wood et al. 2003). There is some evidence that airway oxidative stress, in
contrast to airway inflammation, is resistant to treatment with anti-inflammatory
corticosteroids in people with asthma (Montuschi et al. 2002, Shahid et al. 2005). The goal
of this study was to investigate possible associations between biomarkers of airway
inflammation (exhaled NO) and systemic oxidative stress (carbonylated plasma proteins)
with the putative exhaled lipid peroxidation products, ethane and n-pentane.
There is evidence that oxidative damage results from exposure to reactive oxygen species
from the environment and normal metabolic processes. Oxidative damage accumulates over
a lifetime and is partly responsible for aging, thus making elderly subjects more sensitive to
an oxidizing environment and susceptible to oxidative stress (Packer 1995). For these
reasons, we recruited a group of elderly residents in a retirement community located in
Riverside, California. The air quality in this area is particularly poor. It is located downwind
of Los Angeles and local levels of oxidizing atmospheric gases, such as ozone, often exceed
national and state standards (CARB 2007). During 2006, Riverside had 45 days exceeding
the state 1-h standard and 30 days exceeding the national 8-h standard for ozone (the 2006
maximum 8 h average was 0.117 ppm ozone, and the maximum 1 h average was 0.151 ppm
ozone) (CARB 2007).
In this study, 16 elderly subjects were followed over 12 weeks and their exhaled breath was
analyzed using canister sampling and gas chromatography analysis (Kamboures et al. 2005).
Exhaled NO was chosen as a non-invasive measure of airway inflammation and was
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determined using procedures recommended by the American Thoracic Society and
European Respiratory Society (ATS/ERS 2005). Oxidation of certain proteins results in the
formation of carbonyl derivatives, which have known associations with oxidative stress
(Berlett & Stadtman 1997). For this study, enzyme-linked immuno-sorbent assay (ELISA)
techniques were used to measure carbonylated proteins as oxidative stress markers. Mixed
model statistical analysis was performed to investigate possible associations between the
inflammation and oxidative stress biomarkers with breath hydrocarbons. Furthermore, the
relationship between exhaled ethane and n-pentane with various air pollutants (NO, NO2,
and CO) was evaluated.
Methods
Study design
Subjects participating in this study were volunteers residing in a retirement community,
located in Riverside, California. All protocols were approved by the UCI Institutional
Review Board. The group consisted of 16 subjects (13 male, three female) with a mean age
of 83 ± 4 years. All subjects were diagnosed with coronary artery disease, a disease that is
strongly influenced by inflammation (Ridker 2007) and oxidative stress (Espinola-Klein et
al. 2007). For example, over 20 large studies have shown that risk of cardiovascular events
increase with elevations in an inflammatory biomarker (C-reactive protein), with risks
similar to that for elevated low-density lipoproteins and blood pressure (Ridker 2007).
This study was carried out in two 6-week phases with samples obtained once every week.
The first phase was in September and October, 2006, during the warmer months, when there
was more photochemical activity. The second phase was in January and February 2007,
during the cooler months, when there was less photochemical activity. All subjects were
sampled at the same centrally ventilated room during both phases of the study. Subjects
were asked to refrain from exercise, and food or beverage intake 1 h before sample
collection. It is possible that exercise and food and beverage intake before sample collection
may have influenced exhaled gas concentrations, but we did not have sufficient data to test
this.
Hydrocarbons and CO2
Samples for hydrocarbon and CO2 analysis were collected in electropolished 1.9 l stainless
steel canisters that were fitted with Swagelok Nupro metal bellows valves (Figure 1). Prior
to sampling, each canister and valve assembly was baked at 150°C for 24 h, flushed with
ultra-high purity helium, and evacuated to 10−2 Torr. Each canister was fitted with a
disposable 12 inch (30. 5 cm) long, 0.25 inch (0. 6 cm) diameter Teflon tube through which
the subjects exhaled. One breath sample and one simultaneous background room sample
were obtained from each subject on each sampling date. Subjects were directed to take three
tidal breaths, each time exhaling through the tube, before filling lungs to total capacity and
exhaling into the evacuated canister. In order to avoid upper airway contamination of the
sample, the initial 2 s of the exhaled breath was bypassed at the canister valve and not
collected.
A persistent problem associated with the measurement of exhaled hydrocarbons is the
accounting for hydrocarbons that are present in the inspired air. Often the differences in
ambient air concentrations and exhaled breath concentrations are very small, which makes
the detection of small endogenous produced hydrocarbons challenging. Different procedures
have been used to account for background hydrocarbon concentrations (Cope 2005). In one
of these techniques, the subject breathes ‘hydrocarbon free’ air to washout the lung before a
breath sample is collected. However, the purity of synthetic ‘hydrocarbon free’ air is highly
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variable and can have total hydrocarbon concentrations as high as 1 ppm (Cope 2005). In the
present study, the subjects were allowed to breathe ambient air before collection of the
exhaled sample. When this approach is used, it is important that an ambient sample is
collected simultaneously for each breath sample because ambient hydrocarbon
concentrations can vary greatly over a relatively short period of time (Kamboures et al.
2005). Previous studies have found that the washout time needed to remove ambient ethane
and n-pentane from the airway is 5–10 min (Kanoh et al. 2005, Drury et al. 1997, Lärstad et
al. 2007). It cannot be ruled out that the strong associations between room and exhaled
hydrocarbons would not have been as strong when using washout techniques.
Breath and room samples were analyzed for hydrocarbons by cryogenic preconcentration
and injection (264 cm3 at STP) into a multi-column/detector chromatography system, which
has been described in detail elsewhere (Colman et al. 2001). This system employed the use
of two flame ionization detectors (FID), two electron capture detectors (ECD), and a
quadropole mass spectrometer. Trace gases were quantified using five different column/
detector combinations: DB-1/FID, PLOT+DB-1/FID, Restek1701/ECD, DB-5+Restek1701/
ECD and DB-5 ms/MSD. The breath and room samples were also analyzed for CO2 using a
separate GC system. For analysis of CO2, aliquots of sample were injected onto a
Carbosphere 80/100 packed column output to a thermal conductivity detector (TCD).
Alveolar gradient concentrations of exhaled gases were calculated by subtracting the
background room concentration from the corresponding breath concentration. Quoted
uncertainties for the linear least-squares analysis of the data are two standard deviations
from the regression results.
Exhaled NO
Exhaled NO was measured using standardized ATS/ERS-procedures (ATS/ERS 2005), with
modifications suggested by Linn & Gong (2004), involving collection of exhalate into a
non-reactive 1.5 l Mylar reservoir bag (Ionics Inc., Boulder, CO, USA) for later chemical
analysis. Subjects inhaled orally to total lung capacity and then immediately performed a
slow vital capacity manoeuvre into an offline apparatus attached to a Mylar bag. During
sampling a flow rate of 100 ml s−1 was maintained. Approximately 200 ml of dead-space air
was vented over 2 s prior to collecting the bag sample to reduce contamination from the
upper airways (Jöbsis et al. 2001). To control for inspired ambient NO, an NO/NO2
chemisorbent filter was placed at the air intake of the apparatus, and subjects breathed
through it for 15 s (≥ 2 tidal breaths) before sampling. Three breath samples were collected
to assess reliability. Mylar bags were sealed, refrigerated at 6°C, and analyzed within 20 h
for FENO concentration with a chemiluminescence NO analyzer (NOA™ 280i Sievers, GE
Analytical Instruments, Boulder, CO, USA). To address intravariability among the three
samples per subject we first calculated the within-individual variability and then averaged
these estimates across the population (Chinn 1991). Pairs that were within two standard
deviations of this within-individual population average were retained and all such pairs were
then averaged to obtain a single measurement.
Carbonylated proteins
Blood samples were collected from the subjects on each of the study dates. A protein
carbonyl ELISA kit was used for the direct measurement of dinitrophenylhydrazine
(DNPH)-derivatized carbonyl proteins (Cell Biolabs, San Diego, CA, USA). Total plasma
protein content of each sample was determined by using the BCA Protein Assay kit (Pierce
Biotechnology, Rockford, IL, USA) to express carbonyl concentrations in nmol mg−1
protein. As discussed in detail by Requena et al. (2000), the predominant carbonyl products
resulting from protein oxidation are glutamic and aminoadipic semialdehydes.
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Indoor and outdoor pollution
Indoor and outdoor home measurements of air pollutants and weather variables were made
at the retirement community. These data were used to limit exposure error expected when
using available regional air monitoring data. Air samplers were placed at an indoor location
adjacent to areas of the retirement community where the majority of activities occur.
Outdoor home samplers were placed in an air monitoring trailer supplied by the California
Air Resource Board. Continuous (1-min) NO and NO2 measurements were obtained both
indoors and outdoors by using Thermo Environmental NOx Analyzers (Model 42, Thermo
Environmental Instruments Inc, Franklin, MA, USA). Dasibi Carbon Monoxide Analyzers
(Model 3008, Dasibi Environmental Corp, Glendale, CA, USA) were used to measure
continuous (1-min integrated) indoor and outdoor CO levels.
Mixed model description and statistical analysis
Linear mixed effects models (Verbeke & Molenberghs 2001) were used to estimate the
association of the dependent variables FENO and carbonylated proteins with the exhaled
hydrocarbons, and between exhaled hydrocarbons as a dependent variable with the criteria
pollutant gases. This model structure appropriately handles the correlation present when
repeated measures are taken on individuals over time. We selected a two-stage hierarchical
model with random effects at the subject level. An autoregressive covariance structure was
used for the random effects, allowing the correlation between repeated measures to decrease
with time. Residual diagnostics were conducted to investigate the presence of influential
data points and deviations from assumed functional form. We found that outliers more than
three standard deviations from the mean hydrocarbon distribution influenced many of the
models. Therefore, we present the data with and without these outliers.
Results and discussion
Using the analytical method described above, 57 trace gases were identified and quantified
in the exhaled breath samples. For the purpose of the present study, only concentrations of
exhaled ethane and n-pentane are reported.
The measurements for ethane and n-pentane are shown in Figure 2. As seen in Figure 2,
there is a strong correlation between the breath and room hydrocarbon concentrations (R2 =
0.93 and 0.74, for ethane and n-pentane, respectively). Assuming a linear relationship
between breath and room hydrocarbon concentrations, least-squares analysis of the data in
Figure 2 give slopes of 1.06 ± 0.05 for ethane and 1.06 ± 0.10 for n-pentane. Slopes larger
than 1 indicate that the rate of clearance from the lung is larger than the uptake within the
lung. Both hydrocarbons are slightly elevated in the breath samples in comparison to the
room samples, although within the measurement uncertainties, the breath to room ratios are
indistinguishable from each other and there is no statistically significant difference between
breath and room for these two gases. Figure 2 shows that background room hydrocarbon
concentrations varied by more than a factor of 3 during the study period, and illustrates the
importance of obtaining accurate room air samples simultaneously with each breath sample.
Hence, for the following analyses, room air was subtracted from breath air, and breath
hydrocarbons were normalized to exhaled CO2 to obtain an estimate of endogenously
produced ethane and n-pentane. One of the limitations that must be considered when using
this technique is the possibility that residual ethane and n-pentane in the airways is not fully
accounted for by subtracting background room concentrations.
The relationship between ethane and n-pentane with exhaled NO was evaluated using
bivariate and mixed model analysis. Figure 3 shows the alveolar gradients for ethane and n-
pentane plotted versus exhaled NO. Exhaled hydrocarbon concentrations are normalized to
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exhaled CO2, which had a mean concentration of 4.3 ± 0.7% (1σ). Assuming that exhaled
NO is a marker for airway inflammation, a simple bivariate correlation could be indicative
of an association between oxidative stress and airway inflammation. As seen from Figure 3,
there are no significant correlations between exhaled ethane or n-pentane with exhaled NO
(R2ethane = 0.02 and R2n-pentane = 0.0005). As seen from Table 1, a mixed linear regression
analysis of the data, as described above, also failed to show any significant association
between the exhaled hydrocarbons and exhaled NO. This suggests that the short chain
alkanes in exhaled breath are not related to airway inflammatory processes and may not be
biomarkers of oxidative stress.
A mixed model analysis was also used to evaluate the relationship between the exhaled
hydrocarbons and carbonylated proteins. Carbonylated proteins are primarily associated
with protein oxidation, but also reflect oxidative mediated lipid peroxidation via the
formation of carbonyl-protein adducts. A positive association between hydrocarbons and
carbonylated proteins would suggest that an increase in exhaled hydrocarbons could be
indicative of oxidative stress. As shown in Table 2, there is no significant association
between the hydrocarbons and the carbonylated proteins when outliers were included.
Without the inclusion of outliers, still no significant association between ethane and the
carbonylated proteins exists, while the association between n-pentane and the carbonylated
proteins is significant, but negative. As the results show, no positive relationship was
identified between exhaled hydrocarbons and carbonylated proteins.
Continuous measurements of outdoor and indoor gaseous air pollutants (NO, NO2, and CO)
were performed in order to look for relationships with exhaled concentrations of ethane and
n-pentane. By examining the relationship between exhaled hydrocarbons and indoor/outdoor
air pollutants it is possible to evaluate to what extent atmospheric pollutants influence
concentrations of exhaled ethane and/or n-pentane. The indoor and outdoor criteria air
pollutant measurements are summarized in Table 3. The change in hydrocarbon per
interquartile range (IQR) increase in the air pollutant is listed in Table 4. The influence of
exposure to criteria pollutants was investigated by using the average concentrations of
criteria pollutants for the previous 1 h as well as the previous 8 h. Model results are reported
in Table 4, with and without inclusion of outliers in high exhaled ethane and n-pentane
concentrations (>3σ). Inclusion of the outliers significantly reduces the estimated
hydrocarbon change per IQR pollutant gas toward zero and confidence limits widen. Figures
4 and 5 show the change in hydrocarbon per IQR increase in air pollutant with outliers
removed for high exhaled ethane and n-pentane concentrations. In general, the criteria
pollutant gases were positively associated with the exhaled breath gases. The most
significant change in hydrocarbon per change in IQR pollutant gas is for the 1-h NO
average, although this estimate does not exceed 0.015 (pptv/ppmv). Finally, the results using
1-h pollutant averages are consistently higher relative to the 8-h averages.
The relationship between indoor hydrocarbons (ethane and n-pentane) with indoor air
pollutants (NO, NO2, and CO) was also evaluated. Table 5 summarizes the associations
between each of these relationships. Significant associations were found between the
hydrocarbons and NOx, and to a lesser extent CO. This suggests that increased exhaled
hydrocarbons could be a result of exposure to higher ambient levels of hydrocarbons during
air pollution events. If this was the case, elevated levels of exhaled hydrocarbons may be
predominantly a marker of exposure to a polluted environment, thus overwhelming any
small signal of oxidative stress.
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Conclusion
The present work investigates the associations between a biomarker of airway inflammation
(exhaled NO), a biomarker of oxidative stress as measured by protein oxidation
(carbonylated proteins), and two suspected biomarkers of oxidative stress (exhaled ethane
and n-pentane). Sixteen subjects were studied each with up to 12 repeated measures.
Subjects reside in a highly polluted and oxidizing environment and are at high risk for
developing oxidative stress that could induce airway inflammation. Simultaneous
background sampling showed hydrocarbon concentrations in breath being slightly, but not
significantly, elevated over room air samples. Analysis of exhaled concentrations of ethane
and n-pentane from elderly subjects did not show significant associations with exhaled NO,
which is a widely employed marker of airway inflammation (Choi et al. 2006, Gustafsson
2005). Additionally, neither of the exhaled hydrocarbons had positive associations with
carbonylated proteins measured in the blood, which are indicative of oxidative stress.
Finally, positive but weak associations between measurements of exhaled hydrocarbons
(ethane and n-pentane) and air pollutants (NOx and CO) were observed. It is conceivable
that exposure to higher levels of gaseous air pollutants has a weak but significant impact on
exhaled ethane and n-pentane. This may be secondary to residual ethane and n-pentane in
the airways not adjusted for by subtracting room ethane and n-pentane from exhaled breath
concentrations. Assuming that these hydrocarbon gases are positively correlated to the
criteria gases in both outdoor and indoor environments that the subjects have been exposed
to, it is possible that the association is not casual but instead a reflection of air pollutant
levels.
This study suggests exhaled ethane and n-pentane are not sufficiently accurate markers of
oxidative stress or airway inflammation, but instead are markers of previous exposure to air
pollutants.
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Figure 1.
Diagram of a hydrocarbon/CO2 breath sampling apparatus.
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Figure 2.
Exhaled breath concentrations versus room air concentrations for ethane (A) and n-pentane
(B).
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Figure 3.
Correlation of exhaled ethane (A) and n-pentane (B) with exhaled NO. Exhaled hydrocarbon
concentrations are normalized to exhaled CO2.
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Figure 4.
Relationship between change in exhaled ethane and indoor (A) and outdoor air (B)
pollutants using the last 1-h concentration average (solid symbols) and the last 8-h
concentration average (open symbols) for NO, NO2 and CO, respectively.
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Figure 5.
Relationship between change in n-pentane and indoor (A) and outdoor (B) air pollutants
using the last 1-h concentration average (solid symbols) and the last 8-h concentration
average (open symbols) for NO, NO2 and CO, respectively.
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Table 1
Statistical evaluation of exhaled ethane and n-pentane as predictors of exhaled NO.
DF
Mixed model estimate
(95% confidence limits) p-Value
Outliersa retained
Ethane 147 1.7 (−60.3, 63.7) 0.96
n-Pentane 151 −62.8 (−222.2, 96.6) 0.44
Outliersa removed
Ethane 145 −0.3 (−70.4, 69.8) 0.99
n-Pentane 147 −86.9 (−277.4, 103.6) 0.37
aOutliers are defined as observations 3 standard deviations beyond the mean of the predictor.
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Table 2
Statistical evaluation of exhaled ethane and n-pentane as predictors of carbonylated proteins.
DF
Mixed model estimate
(95% confidence limits) p-Value
Outliersa retained
Ethane 124 −0.0040 (−0.036, 0.028) 0.81
n-Pentane 128 −0.034 (−0.097, 0.028) 0.28
Outliersa removed
Ethane 118 −0.018 (−0.087, 0.050) 0.59
n-Pentane 123 −0.11 (−0.21, −0.0096) 0.032
aOutliers are defined as observations 3 standard deviations beyond the mean of the predictor.
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Table 3
Summary of indoor and outdoor air pollution measurements.
Mean Standard deviation
Indoor (8-h average)
NO (ppbv) 6.63 4.24
NO2 (ppbv) 11.41 2.54
CO (ppmv) 0.50 0.15
Outdoor (8-h average)
NO (ppbv) 5.66 3.87
NO2 (ppbv) 14.13 7.42
CO (ppmv) 0.20 0.13
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Table 4
Statistical evaluation of ethane and n-pentane as markers for exposure to criteria air pollutants (1-h and 8-h
averages). 95% confidence limits are listed in the parentheses.
Change in hydrocarbon per IQR (10−3 pptv/ppmv) Conc. Avg. NO NO2 CO
Hydrocarbon outliersaremoved
Indoor
Ethane 1-h 12.66 (6.94, 18.4) 4.74 (0.43, 9.06) 4.64 (1.77, 7.52)
8-h 6.55 (2.01, 11.1) 4.36 (−0.97, 9.69) 2.76 (−0.14, 5.65)
n-Pentane 1-h 4.52 (1.70, 7.34) 2.52 (0.56, 4.47) 1.16 (−0.20, 2.52)
8-h 2.83 (0.70, 4.97) 1.87 (−0.52, 4.25) 0.05 (−1.24, 1.36)
Outdoor
Ethane 1-h 7.94 (2.91, 12.97) 5.34 (1.35, 9.31) −0.90 (−3.92, 2.13)
8-h 1.62 (−0.99, 4.24) 1.93 (−1.91, 5.78) −3.69 (−6.75, −0.63)
n-Pentane 1-h 3.92 (1.52, 6.32) 3.66 (1.88, 5.44) 2.13 (0.79, 3.46)
8-h 1.49 (0.31, 2.67) 2.48 (0.77, 4.19) 1.46 (0.08, 2.84)
Hydrocarbon outliersaretained
Indoor
Ethane 1-h 12.39 (2.79, 22.00) 4.25 (−2.90, 11.40) 6.62 (1.85, 11.40)
8-h 5.51 (−2.04, 13.06) 3.01 (−5.66, 11.68) 3.11 (−1.67, 7.89)
n-Pentane 1-h 3.97 (−0.03, 7.96) 1.59 (−1.30, 4.49) 0.96 (−1.02, 2.94)
8-h 3.33 (0.33, 6.33) 1.55 (−1.96, 5.07) 0.76 (−1.18, 2.71)
Outdoor
Ethane 1-h 0.41 (−3.85, 4.67) 0.94 (−5.29, 7.17) −2.59 (−7.77, 2.59)
8-h 7.34 (−1.12, 15.80) 4.91 (−1.62, 11.44) 0.64 (−4.44, 5.71)
n-Pentane 1-h 1.45 (−2.09, 4.99) 2.63 (−0.06, 5.31) 2.07 (−0.02, 4.15)
8-h 1.31 (−0.46, 3.07) 2.54 (−0.04, 5.11) 0.98 (−1.18, 3.14)
aOutliers are defined as observations 3 standard deviations beyond the mean of the predictor.
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